New Zealand’s Fonterra … agreed to sell its 50% stake in DFE Pharma for NZ$633 million ($400.37 million) as the world’s biggest dairy exporter trims its overseas portfolio to focus on domestic business. — Reuters

It is a leading global excipients manufacturer for the pharmaceutical industry. DFE Pharma has operations in Europe, India and New Zealand, is headquartered in Germany and has presence in over 100 countries. Fonterra is a global dairy nutrition co-operative headquartered in New Zealand owned by 10,000 farmers. It is the world’s largest dairy exporter and employs around 22,000 people globally, according to PDS.

The primary jurisdiction of the deal was New Zealand.

PDS Legal advised Fonterra Co-operative Group Limited on the Indian leg of the deal led by a team of director Anirudh Mukherjee, principal associate Deepti Thakkar, senior associate Ankit Rustagi and associate Yash Tripathi.

Also advising was Fonterra and FieslandCampina were HVG Law and Allen & Overy respectively.

Rothschild & Co, Freshfields Bruckhaus Deringer and KPMG acted for CVC Capital Partners.

2019-09-25

Deal value: NZ$ 633 m

{incomplete}